Latest Articles

Publication Date
Neurocrine CEO and IR Chief to Share Latest Growth Strategy at Major Biotech Conference - Stock Titan

Neurocrine CEO and IR Chief to Share Latest Growth Strategy at Major Biotech Conference Stock Titan

Published: Aug. 6, 2025, 8:01 p.m.
Actress Janel Parrish Opens Up About Her Battle With Endometriosis - Fangirlish

Actress Janel Parrish Opens Up About Her Battle With Endometriosis Fangirlish

Published: Aug. 6, 2025, 8 p.m.
“Rusty Machete Pain”: Former NC worker files ADA lawsuit over period pain - wfmynews2.com

“Rusty Machete Pain”: Former NC worker files ADA lawsuit over period pain wfmynews2.com

Published: Aug. 6, 2025, 7:43 p.m.
Period pain, disability rights, and a $500K lawsuit: What it means for you - wfmynews2.com

Period pain, disability rights, and a $500K lawsuit: What it means for you wfmynews2.com

Published: Aug. 6, 2025, 7:43 p.m.
AIM ImmunoTech announces four presentations on Ampligen at MSCI MSCS-2025 - TipRanks

AIM ImmunoTech announces four presentations on Ampligen at MSCI MSCS-2025 TipRanks

Published: Aug. 6, 2025, 5:42 p.m.
Cardiff Council Commits to Becoming Endometriosis Friendly Employer - Business News Wales

Cardiff Council Commits to Becoming Endometriosis Friendly Employer Business News Wales

Published: Aug. 6, 2025, 4:44 p.m.
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers - The ASCO Post

Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers The ASCO Post

Published: Aug. 6, 2025, 3:38 p.m.
Modern Gynecology – Challenges, Problems, Prospects: Interview with Doctor of Medical Sciences Volodymyr Terekhov - Open4business.com.ua.

Modern Gynecology – Challenges, Problems, Prospects: Interview with Doctor of Medical Sciences Volodymyr Terekhov Open4business.com.ua.

Published: Aug. 6, 2025, 3:15 p.m.
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database - Frontiers

Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database Frontiers

Published: Aug. 6, 2025, 2:27 p.m.
Gates Foundation to Spend $2.5 Billion on Women’s Health by 2030 - U.S. News & World Report

Gates Foundation to Spend $2.5 Billion on Women’s Health by 2030 U.S. News & World Report

Published: Aug. 6, 2025, 1:40 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!